Bimodal Distribution of Major Cardiovascular Events in Kidney Allograft Recipients

被引:7
作者
Boschiero, L. [1 ]
Fior, F. [1 ]
Nacchia, F. [1 ]
机构
[1] Azienda Osped Verona, Kidney Transplantat Ctr, OCM Borgo Trento, I-37126 Verona, Italy
关键词
RENAL-DISEASE; RISK-FACTORS; TRANSPLANTATION; MORTALITY; DIALYSIS;
D O I
10.1016/j.transproceed.2009.02.047
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Cardiovascular disease (CVD) is the major cause of death after renal transplantation. We have retrospectively analyzed the incidence and the time of appearance of CVD among 870 consecutive cadaveric kidney transplant recipients, including 143 patients (16.5%) who experienced a fatal or nonfatal event after transplantation. Seventy-four recipients (54%) showed a fatal CVD. Studying the various manifestations, we observed a higher frequency of cardiac events (59% of ischemic heart disease), with 15% cerebrovascular disease and 22% peripheral vascular or aortic disease. In our group, CVDs were distributed in a bimodal manner, with a higher incidence in the first posttransplantation year and a late cluster of CVD at 8 years posttransplantation. The risk of death (hazard function) for CVD increased dramatically during the 8th year after transplantation. This trend of CVD after kidney transplantation may be explained by inadequate evaluation and management of CVD risk factors during waiting list time and, after transplantation, by the cumulative effects of traditional and nontraditional risk factors.
引用
收藏
页码:1183 / 1186
页数:4
相关论文
共 11 条
[1]
Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up [J].
Aakhus, S ;
Dahl, K ;
Wideroe, TE .
CLINICAL TRANSPLANTATION, 2004, 18 (05) :596-604
[2]
Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death [J].
Aalten, Jeroen ;
Hoogeveen, Ellen K. ;
Roodnat, Joke I. ;
Weimar, Willem ;
Borm, George F. ;
de Fijter, Johan W. ;
Hoitsma, Andries J. .
TRANSPLANT INTERNATIONAL, 2008, 21 (10) :985-991
[3]
Foley RN, 1998, J AM SOC NEPHROL, V9, P267
[4]
The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients [J].
Gill, J. S. ;
Rose, C. ;
Pereira, B. J. G. ;
Tonelli, M. .
KIDNEY INTERNATIONAL, 2007, 71 (05) :442-447
[5]
Cardiovascular disease in transplant recipients: Current and future treatment strategies [J].
Gill, John S. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 :S29-S37
[6]
Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation [J].
Krämer, BK ;
Zülke, C ;
Kammerl, MC ;
Schmidt, C ;
Hengstenberg, C ;
Fischereder, M ;
Marienhagen, J .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) :982-987
[7]
Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? [J].
Levey, AS ;
Beto, JA ;
Coronado, BE ;
Eknoyan, G ;
Foley, RN ;
Kasiske, BL ;
Klag, MJ ;
Mailloux, LU ;
Manske, CL ;
Meyer, KB ;
Parfrey, PS ;
Pfeffer, MA ;
Wenger, NK ;
Wilson, PWF ;
Wright, JT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :853-906
[8]
Cardiovascular complications after renal transplantation and their prevention [J].
Ojo, Akinlolu O. .
TRANSPLANTATION, 2006, 82 (05) :603-611
[9]
PONTICELLI C, 2007, INFORM HEALTHCARE
[10]
Rice Muriel, 2002, Prog Transplant, V12, P299